HIV in pregnancy
HIV in pregnancy is managed by starting or continuing combination antiretroviral therapy in every HIV-positive pregnant patient regardless of CD4 count or gestational age, because fully suppressive ART drives perinatal transmission below 1%, versus 25 to 30% with no intervention at all.
- Topic reviewThe full article, organized the way the exam asks it.
- ABIM-format MCQsVignettes with an explanation for every wrong answer.
- Key factsThe numbers and thresholds worth memorizing, up front.
- AI tutorMedBrain answers the question you're stuck on.
What this article covers
- Overview
A perinatal transmission problem with a near-curative fix: combination antiretroviral therapy (ART) that fully suppresses the maternal human immunodeficiency virus (HIV) viral load cuts…
- Epidemiology
Untreated vertical transmission is 25 to 30%, mostly via intrapartum exposure; combination ART reduces this to under 1%, far more effective than zidovudine monotherapy alone (about 25% to about 8%), which is never used alone.
- Risk factors
No maternal antiretroviral therapy: the largest driver of transmission; an untreated mother carries the full 25 to 30% baseline risk.
- Pathophysiology
HIV is a retrovirus that integrates into the host genome: a single-stranded, positive-sense, enveloped RNA virus (family Retroviridae); after cell entry, reverse transcriptase converts the RNA genome…
- Clinical features
Most pregnant patients with HIV are asymptomatic: identified by routine opt-out prenatal screening rather than symptoms.
- Differential diagnosis
Acute retroviral syndrome versus another viral syndrome (mononucleosis, influenza, viral hepatitis): fever, pharyngitis, and lymphadenopathy overlap; discriminator is a fourth-generation HIV…
- Diagnosis
Diagnosis is established by a positive fourth-generation HIV-1/2 antigen/antibody combination immunoassay confirmed by an HIV-1/HIV-2 antibody differentiation immunoassay: a reactive screen is…
- Management
First, start (or continue) combination ART immediately upon diagnosis, regardless of trimester, CD4 count, or viral load: a patient already on effective ART continues the same regimen; a…
- Complications
Perinatal transmission and infant infection: the central complication this pathway prevents; an infected infant requires lifelong ART and ongoing specialty care.
- Prognosis
The infant's prognosis hinges on the same lever throughout: transmission risk falls from 25 to 30% to under 1% with fully suppressive ART, delivery-route selection, and breastfeeding avoidance when…
- Prevention
Universal opt-out HIV screening at the first prenatal visit, using the fourth-generation antigen/antibody combination immunoassay, so ART can start as early as possible.
Read the whole article
Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.
Related articles
- Acute HIV infection
Acute HIV infection, also called the acute retroviral syndrome, is the symptomatic viremic phase in the days to weeks after HIV acquisition, presenting with fever, fatigue, myalgia, rash, and pharyngitis at a time when antibody testing may still be negative. Diagnosis requires an HIV RNA viral load, and antiretroviral therapy should begin as soon as the patient is ready, regardless of CD4 count.
- HIV-associated nephropathy (HIVAN)
HIV-associated nephropathy is the collapsing variant of focal segmental glomerulosclerosis seen in HIV infection, driven largely by the high-risk APOL1 genotype, and confirmed by kidney biopsy. Antiretroviral therapy started immediately, plus a tenofovir alafenamide-based regimen and RAS blockade, is the cornerstone of management.
- Syphilis (Treponema pallidum infection)
Syphilis is a sexually transmitted infection with the spirochete Treponema pallidum that progresses through painless chancre (primary), disseminated rash and condyloma lata (secondary), latent, and tertiary stages including neurosyphilis, diagnosed by paired nontreponemal and treponemal serology and treated with a single dose of intramuscular benzathine penicillin G for early disease.
- Toxoplasmosis
Toxoplasmosis is infection with the protozoan Toxoplasma gondii, acquired from undercooked meat or cat feces, causing a mononucleosis-like illness in immunocompetent hosts, reactivation encephalitis with ring-enhancing brain lesions in advanced HIV, and a severe congenital syndrome after maternal primary infection in pregnancy. Diagnosis in CNS disease is largely presumptive on serology, imaging, and empiric treatment response, and management is pyrimethamine-sulfadiazine-leucovorin, with prevention centered on CD4-based prophylaxis and food/cat-litter precautions in pregnancy.
- Hepatitis B virus (HBV) infection
Hepatitis B virus is a bloodborne and sexually transmitted DNA virus that causes acute hepatitis and, when infection becomes chronic, progresses through immune-tolerant, immune-active, immune-control, and reactivation phases toward cirrhosis and hepatocellular carcinoma. Diagnosis rests on hepatitis B serology, chronic infection is treated with entecavir or tenofovir, and reactivation during immunosuppression is prevented with prophylactic antiviral therapy.
- Gestational diabetes mellitus
Gestational diabetes mellitus is carbohydrate intolerance first identified in the second or third trimester, diagnosed with a 50-g glucose challenge test followed by a confirmatory 100-g oral glucose tolerance test. Insulin is first-line pharmacologic therapy when glycemic targets are not met with diet and exercise, and untreated hyperglycemia drives fetal macrosomia, shoulder dystocia, neonatal hypoglycemia, and later maternal type 2 diabetes.
- Cytomegalovirus (CMV) infection
Cytomegalovirus is a ubiquitous herpesvirus that is usually asymptomatic or causes a heterophile-negative mononucleosis-like illness in healthy hosts, but reactivates to cause retinitis, colitis, pneumonitis, or encephalitis in transplant recipients and patients with AIDS; treatment is systemic ganciclovir or valganciclovir, with foscarnet and cidofovir reserved for resistance or intolerance.